Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


Perinatal Phosphatidylcholine Supplementation and Early Childhood Behavior Problems: Evidence for CHRNA7 Moderation.

Ross RG, Hunter SK, Hoffman MC, McCarthy L, Chambers BM, Law AJ, Leonard S, Zerbe GO, Freedman R.

Am J Psychiatry. 2016 May 1;173(5):509-16. doi: 10.1176/appi.ajp.2015.15091188. Epub 2015 Dec 7. Erratum in: Am J Psychiatry. 2016 Jul 1;173(7):735.


Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk.

Ross RG, Hunter SK, McCarthy L, Beuler J, Hutchison AK, Wagner BD, Leonard S, Stevens KE, Freedman R.

Am J Psychiatry. 2013 Mar;170(3):290-8. doi: 10.1176/appi.ajp.2012.12070940. Erratum in: Am J Psychiatry. 2013 May 1;170(5):566.


Long-term improvements in sensory inhibition with gestational choline supplementation linked to α7 nicotinic receptors through studies in Chrna7 null mutation mice.

Stevens KE, Choo KS, Stitzel JA, Marks MJ, Adams CE.

Brain Res. 2014 Mar 13;1552:26-33. doi: 10.1016/j.brainres.2014.01.022. Epub 2014 Jan 23.


The interaction between maternal immune activation and alpha 7 nicotinic acetylcholine receptor in regulating behaviors in the offspring.

Wu WL, Adams CE, Stevens KE, Chow KH, Freedman R, Patterson PH.

Brain Behav Immun. 2015 May;46:192-202. doi: 10.1016/j.bbi.2015.02.005. Epub 2015 Feb 12.


Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.

Stevens KE, Zheng L, Floyd KL, Stitzel JA.

Brain Res. 2015 Jun 22;1611:8-17. doi: 10.1016/j.brainres.2015.02.044. Epub 2015 Mar 2.


Brief Report: Initial Trial of Alpha7-Nicotinic Receptor Stimulation in Two Adult Patients with Autism Spectrum Disorder.

Olincy A, Blakeley-Smith A, Johnson L, Kem WR, Freedman R.

J Autism Dev Disord. 2016 Dec;46(12):3812-3817.


Permanent improvement in deficient sensory inhibition in DBA/2 mice with increased perinatal choline.

Stevens KE, Adams CE, Yonchek J, Hickel C, Danielson J, Kisley MA.

Psychopharmacology (Berl). 2008 Jun;198(3):413-20. doi: 10.1007/s00213-008-1170-3. Epub 2008 Apr 30.


Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.

Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kem WR, Freedman R.

Arch Gen Psychiatry. 2006 Jun;63(6):630-8.


The α7 nicotinic acetylcholine receptor and the acute stress response: maternal genotype determines offspring phenotype.

Sinkus ML, Wamboldt MZ, Barton A, Fingerlin TE, Laudenslager ML, Leonard S.

Physiol Behav. 2011 Aug 3;104(2):321-6. doi: 10.1016/j.physbeh.2010.11.007. Epub 2010 Nov 10.


Creating opportunities for parent empowerment: program effects on the mental health/coping outcomes of critically ill young children and their mothers.

Melnyk BM, Alpert-Gillis L, Feinstein NF, Crean HF, Johnson J, Fairbanks E, Small L, Rubenstein J, Slota M, Corbo-Richert B.

Pediatrics. 2004 Jun;113(6):e597-607.


No association between CHRNA7 microsatellite markers and attention-deficit hyperactivity disorder.

Kent L, Green E, Holmes J, Thapar A, Gill M, Hawi Z, Fitzgerald M, Asherson P, Curran S, Mills J, Payton A, Craddock N.

Am J Med Genet. 2001 Dec 8;105(8):686-9.


CHRFAM7A: a human-specific α7-nicotinic acetylcholine receptor gene shows differential responsiveness of human intestinal epithelial cells to LPS.

Dang X, Eliceiri BP, Baird A, Costantini TW.

FASEB J. 2015 Jun;29(6):2292-302. doi: 10.1096/fj.14-268037. Epub 2015 Feb 13.


Cholinergic modulation of auditory P3 event-related potentials as indexed by CHRNA4 and CHRNA7 genotype variation in healthy volunteers.

Hyde M, Choueiry J, Smith D, de la Salle S, Nelson R, Impey D, Baddeley A, Aidelbaum R, Millar A, Knott V.

Neurosci Lett. 2016 Jun 3;623:36-41. doi: 10.1016/j.neulet.2016.04.040. Epub 2016 Apr 22.


α7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia.

Freedman R.

Annu Rev Med. 2014;65:245-61. doi: 10.1146/annurev-med-092112-142937. Epub 2013 Oct 9. Review.


Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases.

Lin H, Hsu FC, Baumann BH, Coulter DA, Lynch DR.

Neurobiol Dis. 2014 Mar;63:129-40. doi: 10.1016/j.nbd.2013.11.021. Epub 2013 Dec 8.


Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.

Lin H, Hsu FC, Baumann BH, Coulter DA, Anderson SA, Lynch DR.

Mol Cell Neurosci. 2014 Jul;61:163-75. doi: 10.1016/j.mcn.2014.06.007. Epub 2014 Jun 28.


The effects of prenatal stress on alpha4 beta2 and alpha7 hippocampal nicotinic acetylcholine receptor levels in adult offspring.

Schulz KM, Andrud KM, Burke MB, Pearson JN, Kreisler AD, Stevens KE, Leonard S, Adams CE.

Dev Neurobiol. 2013 Nov;73(11):806-14. doi: 10.1002/dneu.22097. Epub 2013 Sep 17.


Chrna7 genotype is linked with alpha7 nicotinic receptor expression but not alpha7 RNA levels.

Brooks NP, Mexal S, Stitzel JA.

Brain Res. 2009 Mar 31;1263:1-9. doi: 10.1016/j.brainres.2009.01.026. Epub 2009 Feb 7.


CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders.

Kunii Y, Zhang W, Xu Q, Hyde TM, McFadden W, Shin JH, Deep-Soboslay A, Ye T, Li C, Kleinman JE, Wang KH, Lipska BK.

Am J Psychiatry. 2015 Nov 1;172(11):1122-30. doi: 10.1176/appi.ajp.2015.14080978. Epub 2015 Jul 24.


Prenatal ablation of nicotinic receptor alpha7 cell lineages produces lumbosacral spina bifida the severity of which is modified by choline and nicotine exposure.

Rogers SW, Tvrdik P, Capecchi MR, Gahring LC.

Am J Med Genet A. 2012 May;158A(5):1135-44. doi: 10.1002/ajmg.a.35372. Epub 2012 Mar 30.

Supplemental Content

Support Center